HK1223307A1 - 新型化合物和其用途 - Google Patents

新型化合物和其用途 Download PDF

Info

Publication number
HK1223307A1
HK1223307A1 HK16111737.7A HK16111737A HK1223307A1 HK 1223307 A1 HK1223307 A1 HK 1223307A1 HK 16111737 A HK16111737 A HK 16111737A HK 1223307 A1 HK1223307 A1 HK 1223307A1
Authority
HK
Hong Kong
Prior art keywords
diseases
pharmaceutical compositions
compounds
formulae
growth factor
Prior art date
Application number
HK16111737.7A
Other languages
English (en)
Chinese (zh)
Inventor
Ben C. Askew
Andrew Good
Winston Zapanta ONG
Pawel Wojciech Nowak
Original Assignee
Kala Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kala Pharmaceuticals, Inc. filed Critical Kala Pharmaceuticals, Inc.
Publication of HK1223307A1 publication Critical patent/HK1223307A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Transplantation (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HK16111737.7A 2013-05-30 2014-05-30 新型化合物和其用途 HK1223307A1 (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361829117P 2013-05-30 2013-05-30
US61/829,117 2013-05-30
US201361898719P 2013-11-01 2013-11-01
US61/898,719 2013-11-01
PCT/US2014/040231 WO2014197313A2 (en) 2013-05-30 2014-05-30 Novel compounds and uses thereof

Publications (1)

Publication Number Publication Date
HK1223307A1 true HK1223307A1 (zh) 2017-07-28

Family

ID=52008726

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16111737.7A HK1223307A1 (zh) 2013-05-30 2014-05-30 新型化合物和其用途

Country Status (7)

Country Link
US (5) US9988386B2 (https=)
EP (1) EP3003314B1 (https=)
JP (1) JP6557654B2 (https=)
AU (1) AU2014275198B2 (https=)
CA (1) CA2913417A1 (https=)
HK (1) HK1223307A1 (https=)
WO (1) WO2014197313A2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1223307A1 (zh) * 2013-05-30 2017-07-28 Kala Pharmaceuticals, Inc. 新型化合物和其用途
CA2962919C (en) * 2014-09-30 2024-01-02 Transitions Optical, Inc. Ultraviolet light absorbers
US10253045B2 (en) * 2014-11-26 2019-04-09 Kala Pharmaceuticals, Inc. Crystalline forms of a therapeutic compound and uses thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004517080A (ja) * 2000-11-29 2004-06-10 グラクソ グループ リミテッド Ｔｉｅ−２および／またはｖｅｇｆｒ−２の阻害剤として有用なベンゾイミダゾール誘導体
US7531553B2 (en) * 2003-03-21 2009-05-12 Amgen Inc. Heterocyclic compounds and methods of use
EP2058309A4 (en) * 2006-08-04 2010-12-22 Takeda Pharmaceutical CONDENSED HETEROCYCLIC COMPOUND
AU2007279595A1 (en) 2006-08-04 2008-02-07 Takeda Pharmaceutical Company Limited Fused heterocyclic derivative and use thereof
AR067326A1 (es) * 2007-05-11 2009-10-07 Novartis Ag Imidazopiridinas y pirrolo -pirimidinas sustituidas como inhibidores de cinasa de lipido
JP5350247B2 (ja) 2007-08-29 2013-11-27 武田薬品工業株式会社 複素環化合物およびその用途
JPWO2009096435A1 (ja) * 2008-01-29 2011-05-26 武田薬品工業株式会社 縮合複素環誘導体およびその用途
WO2010032880A2 (en) 2008-09-19 2010-03-25 Takeda Pharmaceutical Company Limited Prophylactic/therapeutic agent for cancer
JP2010126530A (ja) * 2008-12-01 2010-06-10 Takeda Chem Ind Ltd 縮合複素環誘導体およびその用途
CN111700879A (zh) 2012-05-03 2020-09-25 卡拉制药公司 显示提高的粘膜转移的药物纳米粒子
JP6360039B2 (ja) 2012-05-03 2018-07-18 カラ ファーマシューティカルズ インコーポレイテッド 複数の被覆された粒子を含む組成物、医薬組成物、医薬製剤、及び当該粒子の形成方法
HK1223307A1 (zh) * 2013-05-30 2017-07-28 Kala Pharmaceuticals, Inc. 新型化合物和其用途

Also Published As

Publication number Publication date
US20190023710A1 (en) 2019-01-24
JP6557654B2 (ja) 2019-08-07
US10544151B2 (en) 2020-01-28
EP3003314A2 (en) 2016-04-13
AU2014275198A1 (en) 2015-12-10
US20160137646A1 (en) 2016-05-19
US20200157106A1 (en) 2020-05-21
EP3003314B1 (en) 2019-05-15
WO2014197313A3 (en) 2015-04-16
CA2913417A1 (en) 2014-12-11
JP2016520617A (ja) 2016-07-14
US9988386B2 (en) 2018-06-05
US10351570B2 (en) 2019-07-16
WO2014197313A2 (en) 2014-12-11
US20210380588A1 (en) 2021-12-09
EP3003314A4 (en) 2017-03-08
US10954244B2 (en) 2021-03-23
AU2014275198B2 (en) 2017-04-13
US20180251467A1 (en) 2018-09-06

Similar Documents

Publication Publication Date Title
WO2014201127A3 (en) Urea derivatives and uses thereof
CL2015000628A1 (es) Derivados tricíclicos de quinolinas y de quinoxalinas.
CL2016001629A1 (es) Compuestos tricíclicos como agentes anticancerígenos
PH12016501898B1 (en) Quinoxaline derivatives useful as fgfr kinase modulators
MX2017004579A (es) Estructuras fibrosas solubles y metodos para fabricarlas.
MX2015011132A (es) Moduladores policiclicos del receptor de estrogenos y sus usos.
BR112017002963A2 (pt) derivados citotóxicos de benzodiazepina
CL2014001243A1 (es) Compuestos derivados de 4-pregenen-11beta-17-21-triol-3,20-diona, moduladores de los receptores glucocorticoide o mineralocorticoide; composicion farmaceutica; metodo de tratamiento de condiciones oculares tales como ojo seco, blefaritis, rosacea ocular, uveitis y degeneracion macular entre otras.
EP3060143A4 (en) Maintenance of bronchial patency by local delivery of cytotoxic, cytostatic, or anti-neoplastic agent
CL2016002091A1 (es) Compuesto de triazina y su uso para fines medicinales
EP4268843A3 (en) Improved il-6 antibodies
WO2015108787A3 (en) Compositions and methods for the treatment of intraocular neovascularization and/or leakage
WO2015109135A3 (en) Articles with improved flame retardancy and/or melt dripping properties
IL250022B (en) 1-(pyrimidin-2-yl)-6-(heterocyclyl-carbonyl)-(indoline/2,3-dihydroazaindole) derivatives, process for their preparation and pharmaceutical compositions comprising them
WO2012080497A3 (en) Use of lp-pla2 inhibitors in the treatment and prevention of eye diseases
MX2017010422A (es) Imidazolil enonas triciclicas como moduladores de inflamacion antioxidantes.
WO2016061555A3 (en) Novel small molecule anticancer agents
CL2014001959A1 (es) Compuestos derivados de fenil-1h-imidazo[1,2-b]pirazol sustituidos; procedimiento de preparacion; composicion farmaceutica; y el uso en el tratamiento del cancer.
MX2021006070A (es) Formulaciones oculares para la administracion de farmacos y proteccion del segmento anterior del ojo.
HK1223307A1 (zh) 新型化合物和其用途
MX2020012011A (es) Conjugados y derivados de prostaglandina para tratar el glaucoma y la hipertension ocular.
WO2015029035A8 (en) SELECTIVE INHIBITORS OF α2 ISOFORM OF Na,K-ATPase AND USE FOR REDUCTION OF INTRA-OCULAR PRESSURE
FR3018045B1 (fr) Composition ophtalmique remanente, notamment pour le traitement de la secheresse oculaire
HK1225376A1 (en) Urea derivatives and uses thereof
WO2014153643A8 (en) Compositions and methods for use thereof in the treatment of aniridia